Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
Launched by NYU LANGONE HEALTH · Aug 16, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called the VA National TeleOncology program, which helps veterans with cancer by providing healthcare services through telemedicine, or virtual visits. The main goal is to see how effective this program is in improving access to care, the quality of treatment, and managing healthcare costs for veterans diagnosed with lung, colorectal, prostate, or breast cancers. The trial also aims to ensure that all veterans, regardless of their background or circumstances, can benefit equally from these services.
To participate in the trial, you need to be a veteran aged 18 or older who has been newly diagnosed with one of the specified cancers within the last three months. You should also have had an oncology visit at a Veterans Affairs Medical Center. If you haven’t seen a provider at the VA in the past year or have been diagnosed with cancer before, you won’t be eligible. Participants can expect to engage in telehealth visits and share their experiences, helping to improve cancer care for all veterans.
Gender
ALL
Eligibility criteria
- Patients Inclusion Criteria:
- • 1. A Veteran
- • 2. Aged 18 years or older
- • 3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
- • 4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.
- VAMC Providers and Staff Inclusion Criteria:
- • 1. Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans
- • 2. Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location
- Patients Exclusion Criteria:
- • 1. Veterans who have not seen any providers in the VA within the past year
- • 2. Patients previously diagnosed with lung, prostate, breast, or colon cancer
- • 3. Pregnant patients
- VAMC Providers and Staff Exclusion Criteria:
- • 1. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Brooklyn, New York, United States
Jamaica, New York, United States
New York, New York, United States
New York, New York, United States
Staten Island, New York, United States
Patients applied
Trial Officials
Danil Makarov, MD, MHS
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported